Why do most patients fail to respond to the newest cures?
This week’s most thought-provoking papers from the Physics arXiv.
Why the billionaire is wrong that telepathy technology will be available in a few short years.
The maker of the gene therapy Glybera says it doesn’t have enough customers.
Six people in a home can all receive tailored responses from the same device—but it’s still at risk of hijack.
The search giant plans to reach a milestone in computing history before the year is out.
Analysis by Semantic Visions reveals intriguing differences between Russian and Western commentary about the shooting down of an airliner in 2014.
You’ll need strong nerves—and a large wallet—to make use of the world’s first commercially available airborne automobiles.
The most fascinating and important news in technology and innovation delivered straight to your inbox, every day.
The technology has been touted as a powerful diagnostic tool, but it doesn’t provide answers to everyone.